This section of the website is for patients who have been prescribed IQIRVO® (elafibranor) in the UK. Information for members of the general public can be found here.
This medicinal product has a conditional marketing authorisation.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.

PBC & Me: How to take IQIRVO (elafibranor)

Primary Biliary Cholangitis (PBC) Video
09:08

This video helps you understand how to take your treatment correctly and why it matters for managing PBC.

You’ll learn:
• How and when to take elafibranor as prescribed
• Practical tips to help you remember your daily dose
• Why taking your medication consistently is important for slowing disease progression
• What to expect from your regular check-ups and monitoring

It also explains why staying in touch with your healthcare team is key, so you can feel confident that your treatment is working and get support when you need it.

ELA-UK-000418 | July 2026

Explore more Primary Biliary Cholangitis (PBC) Patient Support

Explore more Primary Biliary Cholangitis (PBC) Patient Support

Browse

To access relevant information about Primary Biliary Cholangitis, please confirm the following:

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.